| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 1094 |
| 1 | ALTEPLASE | 1029 |
| 2 | ASPIRIN | 734 |
| 3 | ASPIRIN 325 MG | 691 |
| 4 | ASPIRIN 81 MG | 691 |
| 5 | AMLODIPINE | 505 |
| 6 | ACETAMINOPHEN | 493 |
| 7 | FUROSEMIDE | 461 |
| 8 | OMEPRAZOLE MAGNESIUM | 461 |
| 9 | PREDNISONE | 453 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALTEPLASE | 1029 | 0.0689 |
| 1 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 16 | 0.0278 |
| 2 | CAPLACIZUMAB | 47 | 0.0275 |
| 3 | STANNOUS FLUORIDE | 18 | 0.0251 |
| 4 | SODIUM MONOFLUOROPHOSPHATE | 8 | 0.0244 |
| 5 | AMINOCAPROIC ACID | 18 | 0.0235 |
| 6 | REMIBRUTINIB | 15 | 0.0154 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 40 | 0.0145 |
| 8 | ANTI-INHIBITOR COAGULANT COMPLEX | 13 | 0.0118 |
| 9 | POTASSIUM NITRATE, SODIUM FLUORIDE | 7 | 0.0110 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1431 |
| 1 | Factor Xa Inhibitor [EPC] | 1165 |
| 2 | Corticosteroid [EPC] | 957 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 756 |
| 4 | Kinase Inhibitor [EPC] | 752 |
| 5 | Proton Pump Inhibitor [EPC] | 598 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 585 |
| 7 | Benzodiazepine [EPC] | 579 |
| 8 | Vitamin C [EPC] | 519 |
| 9 | Calcium Channel Blocker [EPC] | 505 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 104 | 0.0069 |
| 1 | Antifibrinolytic Agent [EPC] | 53 | 0.0055 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 95 | 0.0049 |
| 3 | Factor Xa Inhibitor [EPC] | 1165 | 0.0043 |
| 4 | Tricyclic Antidepressant [EPC] | 2 | 0.0042 |
| 5 | Vitamin B6 Analog [EPC] | 1 | 0.0029 |
| 6 | Interferon alpha [EPC] | 154 | 0.0029 |
| 7 | Humanized Monoclonal Antibody Fragment [EPC] | 4 | 0.0028 |
| 8 | CD33-directed Immunoconjugate [EPC] | 10 | 0.0028 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 279 | 0.0024 |